Clinical Trial

Shared Decision Making in Patients With Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to develop a Decision Aid for Lung Cancer Molecular Testing (DA\_LCMT) and to facilitate shared-decision making in patients who were diagnosed with lung adenocarcinoma by intraoperative frozen pathology about whether to conduct the molecular testing.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-01-02; most recent amendment 2026-04-26.
Status change: Not Yet Recruiting → Recruiting 2022-02-22
Trial Details
NCT Number NCT05191485
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Collaborators: Jiangyou People's Hospital, Wu Jieping Medical Foundation, Chongqing Medical University, The Third People's Hospital of Chengdu
Conditions Surgery, Lung Adenocarcinoma
Enrollment 190 participants
Start Date 2023-02-22
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-30